Mun-Gavin David C.

GT Biopharma, Inc. · Director

Mun-Gavin David C. is listed in filings as Director at GT Biopharma, Inc.. This profile follows SEC Form 4 activity through Sep 8, 2025, including 1 public disclosure. Recent filings connect the profile to GT Biopharma, Inc. (GTBP). The current snapshot covers public activity from Sep 8, 2025. Reported amounts are shown as $41.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.